c-myc and bcl-2 expression in supraglottic squamous cell carcinoma of the larynx

Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 1, 2004, Pages 77-83

  Ozdek, Ali ^a,c   Sarac, Sarp ^b   Akyol, M Umut ^b   Sungur, Arzu ^b   Yilmaz, Taner ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CORRELATION ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX SURGERY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE C MYC; PERINEUM; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; GENES, BCL-2; GENES, MYC; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 3142574853     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2004.02.015     Document Type: Article

References (21)

1. Sarac S., Ayhan A., Hosal A.S., et al. Prognostic significance of PCNA expression in laryngeal cancer. Arch Otolaryngol Head Neck Surg. 124:1998;1321-1324
2. Gapany M., Pavelic Z.P., Kelley D.J., et al. Immunohistochemical detection of c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck Surg. 120:1994;255-259
3. Porter M.J., Field J.K., Leung S.F., et al. The detection of the c-myc and Ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol. 114:1994;105-109
4. Miyazaki S., Sasno H., Shiga K., et al. Analysis of c-myc oncogene in human esophageal carcinoma immunohistochemistry, in situ hybridization and Northern and Southern blot studies. Anticancer Res. 12:1992;1747-1756
5. Haughey B.H., Von Hoff D.D., Windle B.E., et al. c-myc oncogene copy number in squamous carcinoma of the head and neck. Am J Otolaryngol. 13:1992;168-171
6. Osmak M., Beketic-Oreskovic L., Matulic M., et al. Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes. Mutat Res. 303:1993;113-120
7. Takes R.P., Baatenburg de Jong R.J., Schuuring E., et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 123:1997;412-419
8. Sakai H., Kawano K., Okamura K., et al. Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. J Oral Pathol Med. 19:1990;1-4
9. Friedman M., Grey P., Venkatesan T.K., et al. Prognostic significance of bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 106:1997;445-450
10. Sarbia M., Bittinger F., Porschen R., et al. Bcl-2 expression and prognosis in squamous cell carcinomas of the esophagus. Int J Cancer. 69:1996;324-328
11. Patel D.D., Bhatavdekar J.M., Chikhlikar P.R., et al. Clinical significance of p53, nm23, and bcl-2 in T3-4 N1M0 oesophageal carcinoma an immunohistochemical approach. J Surg Oncol. 65:1997;111-116
12. Ohbu M., Saegusa M., Kobayashi N., et al. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer. 79:1997;1287-1293
13. Spafford M.F., Koeppe J., Pan Z., et al. Correlation of tumor markers p53, bcl-2, CD34, Cd44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 122:1996;627-632
14. Whisler L.C., Wood N.B., Caldarelli D.D., et al. Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope. 108:1998;630-638
15. Klatka J., Rolinski J., Kupisz K., et al. Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol. 256:1999;299-302
16. Jackel M.C., Sellmann L., Dorudian M.A., et al. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Laryngoscope. 110:2000;1339-1345
17. Hotz M.A., Bosq J., Zbaeren P., et al. Spontaneous apoptosis and the expression of p-53 and bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 125:1999;417-422
18. Fanidi A., Harrington E.A., Evan G.I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 359:1992;554-556
19. Bissonnette R.P., Echeverri F., Mahboubi A., et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:1992;552-554
20. Sarbia M., Loberg C., Wolter M., et al. Expression of bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. Am J Pathol. 155:1999;1027-1032
21. Wang D.G., Liu W.H., Johnston C.F., et al. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis. Am J Pathol. 152:1998;1407-1411